Provided By GlobeNewswire
Last update: Aug 5, 2025
JUPITER, Fla., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (Nasdaq: DYAI), a global biotechnology company focused on the scalable production of high-value, precision engineered functional input proteins for use in life sciences, food and nutrition, and industrial biotechnology applications utilizing its proprietary gene expression platforms, today announced that it will report its financial results for the second quarter 2025 and host a corporate update conference call on Wednesday, August 13, 2025.
Read more at globenewswire.comNASDAQ:DYAI (8/12/2025, 3:52:55 PM)
0.87
+0.06 (+7.41%)
Find more stocks in the Stock Screener